Copyright
©The Author(s) 2021.
World J Diabetes. Dec 15, 2021; 12(12): 2058-2072
Published online Dec 15, 2021. doi: 10.4239/wjd.v12.i12.2058
Published online Dec 15, 2021. doi: 10.4239/wjd.v12.i12.2058
Dose (mIU/ml) | 0 | 15 min | 30 min | 60 min | 120 min | |
Patient 1 | FSH | 0.88 | 1.33 | 1.72 | 2.47 | 3.07 |
LH | 0.66 | 0.98 | 1.22 | 2.31 | 2.67 | |
Patient 2 | FSH | 0.69 | 1.19 | 1.26 | 1.61 | 3.07 |
LH | 0.23 | 0.32 | 0.38 | 0.64 | 2.61 | |
Patient 3 | FSH | 0.85 | 1.29 | 1.64 | 1.88 | 2.42 |
LH | 0.63 | 0.84 | 1.02 | 1.36 | 1.53 | |
Patient 4 | FSH | 0.78 | 1.30 | 1.44 | 1.84 | 2.02 |
LH | 0.68 | 0.94 | 1.29 | 1.33 | 1.63 |
- Citation: Sun SS, Wang RX. Molecular diagnosis of Kallmann syndrome with diabetes by whole exome sequencing and bioinformatic approaches. World J Diabetes 2021; 12(12): 2058-2072
- URL: https://www.wjgnet.com/1948-9358/full/v12/i12/2058.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i12.2058